Emery P, Luqmani R, Gordon C
Department of Rheumatology, University of Birmingham.
Br J Clin Pract. 1994 Mar-Apr;48(2):82-6.
Disease-modifying antirheumatic drugs are used in virtually all patients with established rheumatoid arthritis. An increasingly large number of new drugs is now available. Furthermore, old therapies are being used in novel ways. Treatment is now begun earlier and patients are rarely left untreated. This report summarises recent developments regarding the drugs currently in use and those that may be available in the near future.